Pacific Global Investment Management’s AbbVie ABBV Stock Holding History

Pacific Global Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$1.62M	Sell	7,735 -551	-7%	-$107K	2.29%	19
2024 Q4	$1.47M	Sell	8,286 -12,001	-59%	-$2.21M	1.89%	22
2024 Q3	$4.01M	Sell	20,287 -255	-1%	-$47.6K	0.72%	36
2024 Q2	$3.52M	Buy	20,542 +162	+0.8%	+$26.8K	0.67%	37
2024 Q1	$3.71M	Buy	20,380 +125	+0.6%	+$21.5K	0.71%	37
2023 Q4	$3.14M	Buy	20,255 +211	+1%	+$30.8K	0.64%	39
2023 Q3	$2.99M	Buy	20,044 +463	+2%	+$68K	0.66%	38
2023 Q2	$2.64M	Sell	19,581 -123	-0.6%	-$18K	0.54%	44
2023 Q1	$3.14M	Buy	19,704 +616	+3%	+$94.2K	0.69%	38
2022 Q4	$3.08M	Buy	19,088 +210	+1%	+$32.2K	0.68%	38
2022 Q3	$2.53M	Buy	18,878 +232	+1%	+$33.3K	0.62%	38
2022 Q2	$2.86M	Buy	18,646 +157	+0.8%	+$24K	0.67%	39
2022 Q1	$3M	Buy	18,489 +177	+1%	+$25.7K	0.59%	44
2021 Q4	$2.48M	Buy	18,312 +2,388	+15%	+$282K	0.46%	52
2021 Q3	$1.72M	Buy	15,924 +146	+0.9%	+$16.7K	0.35%	69
2021 Q2	$1.78M	Buy	15,778 +431	+3%	+$48.5K	0.35%	67
2021 Q1	$1.66M	Buy	15,347 +433	+3%	+$46.3K	0.35%	72
2020 Q4	$1.6M	Buy	14,914 +4,834	+48%	+$465K	0.35%	67
2020 Q3	$883K	Sell	10,080 -123	-1%	-$11.6K	0.23%	90
2020 Q2	$1M	Sell	10,203 -6,418	-39%	-$565K	0.28%	79
2020 Q1	$1.27M	Sell	16,621 -1,631	-9%	-$139K	0.4%	67
2019 Q4	$1.62M	Buy	18,252 +623	+4%	+$51.7K	0.35%	80
2019 Q3	$1.33M	Sell	17,629 -7,531	-30%	-$516K	0.31%	88
2019 Q2	$1.83M	Sell	25,160 -1,233	-5%	-$96.9K	0.43%	70
2019 Q1	$2.13M	Buy	26,393 +158	+0.6%	+$12.9K	0.47%	69
2018 Q4	$2.42M	Sell	26,235 -186	-0.7%	-$16.4K	0.6%	54
2018 Q3	$2.5M	Buy	26,421 +724	+3%	+$68.7K	0.51%	67
2018 Q2	$2.38M	Buy	25,697 +2	+0%	+$195	0.52%	62
2018 Q1	$2.43M	Sell	25,695 -75	-0.3%	-$8.24K	0.55%	55
2017 Q4	$2.49M	Buy	25,770 +357	+1%	+$33.6K	0.54%	58
2017 Q3	$2.26M	Sell	25,413 -468	-2%	-$35.6K	0.51%	62
2017 Q2	$1.88M	Sell	25,881 -1,097	-4%	-$73.7K	0.43%	75
2017 Q1	$1.76M	Sell	26,978 -419	-2%	-$26.3K	0.35%	89
2016 Q4	$1.72M	Sell	27,397 -81	-0.3%	-$4.94K	0.35%	87
2016 Q3	$1.73M	Buy	27,478 +29	+0.1%	+$1.88K	0.38%	85
2016 Q2	$1.7M	Sell	27,449 -30	-0.1%	-$1.83K	0.39%	83
2016 Q1	$1.57M	Buy	27,479 +399	+1%	+$22.2K	0.35%	92
2015 Q4	$1.6M	Buy	27,080 +79	+0.3%	+$4.55K	0.36%	90
2015 Q3	$1.47M	Buy	27,001 +243	+0.9%	+$15.8K	0.33%	95
2015 Q2	$1.8M	Sell	26,758 -1,621	-6%	-$106K	0.34%	88
2015 Q1	$1.66M	Sell	28,379 -202	-0.7%	-$12.2K	0.31%	86
2014 Q4	$1.87M	Buy	28,581 +607	+2%	+$38.3K	0.33%	82
2014 Q3	$1.62M	Sell	27,974 -590	-2%	-$32.8K	0.27%	83
2014 Q2	$1.61M	Sell	28,564 -1,511	-5%	-$79.3K	0.24%	83
2014 Q1	$1.55M	Buy	30,075 +358	+1%	+$18.1K	0.24%	81
2013 Q4	$1.57M	Sell	29,717 -217	-0.7%	-$10.7K	0.26%	80
2013 Q3	$1.34M	Sell	29,934 -13	-0%	-$576	0.26%	83
2013 Q2	$1.24M	Buy	+29,947	New	+$1.31M	0.23%	82

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pacific Global Investment Management's ABBV Position: Q1 2025 in Review

Pacific Global Investment Management reduced its AbbVie (ABBV) stake by 6.6% in Q1 2025, selling an estimated $107K and leaving 7,735 shares worth $1.62M. The position accounts for 2.29% of the portfolio, ranked #19.

Pacific Global Investment Management first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.01M in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Pacific Global Investment Management held 7,735 shares of AbbVie worth $1.62M as of Q1 2025.
Pacific Global Investment Management sold 551 AbbVie shares in Q1 2025, an estimated $107K.
AbbVie made up 2.29% of Pacific Global Investment Management's portfolio in Q1 2025, its #19 holding.
Pacific Global Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
Pacific Global Investment Management's AbbVie position peaked at $4.01M in Q3 2024.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Pacific Global Investment Management's 13F filing for Q1 2025, filed 24 Apr 2025.